Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.54 |
| ▸ | NPY4R | P50391 | 2/20 | 0.49 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 8/20 | 0.45 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30139996 | 0.98 | FOLH1 (0.55) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL30527857 | 0.98 | FOLH1 (0.55) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31375133 | 0.98 | FOLH1 (0.55) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL29531274 | 0.98 | FOLH1 (0.55) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31097666 | 0.96 | FOLH1 (0.56) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31097691 | 0.96 | FOLH1 (0.56) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31097720 | 0.96 | FOLH1 (0.56) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31097742 | 0.95 | FOLH1 (0.58) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31097663 | 0.95 | FOLH1 (0.58) | FOLH1NPY4RNPY1RNPY2RBACE1 | |
| SCHEMBL31097692 | 0.95 | FOLH1 (0.58) | FOLH1NPY4RNPY1RNPY2RBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | GLA, ALG3, ANXA6 | FOLH1 3861/4885NPY4R 397/4885NPY1R 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.